Fig. 1From: Longer-term recurrence rate after low versus high dose radioiodine ablation for differentiated thyroid Cancer in low and intermediate risk patients: a meta-analysisFlow chart showing the process for inclusion and exclusion of trials, according to the PRISMA guidelinesBack to article page